Assertio Holdings Inc Quick Ratio (ASRT) starting from the first quarter 2026 to first quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Assertio Holdings inc   (NASDAQ: ASRT)

Assertio Holdings Inc 's Quick Ratio

ASRT's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Assertio Holdings Inc 's Cash & cash equivalent grew by 12.88 % in the Q1 2026 sequentially, while Current Liabilities decreased, this led to improvement in Assertio Holdings Inc 's Quick Ratio to 0.78, Quick Ratio remained below Assertio Holdings inc average.

Within Major Pharmaceutical Preparations industry 335 other companies have achieved higher Quick Ratio than Assertio Holdings Inc in first quarter 2026. While Quick Ratio total ranking has improved so far during the Q1 2026 to 1664, from total ranking in the fourth quarter 2025 at 1723.

Explain Quick Ratio?
How much Cash & cash equivalents ASRT´s has?
What are ASRT´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ASRT Quick Ratio (Mar 31 2026)
Q1		 (Dec 31 2025)
Q4		 (Sep 30 2025)
Q3		 (Jun 30 2025)
Q2		 (Mar 31 2025)
Q1
Y / Y Current Liabilities Change -28.92 % 11.7 % 85.1 % 43.77 % 39.36 %
Y / Y Cash & cash equivalent Change -18.04 % -36.63 % 5.47 % 11.09 % 8.15 %
Quick Ratio MRQ 0.78 0.49 0.56 0.74 0.68
ASRT's Total Ranking # 1664 # 1723 # 2036 # 1552 # 1549
Seq. Current Liabilities Change -28.52 % -23.19 % 25.85 % 2.87 % 12.33 %
Seq. Cash & cash equivalent Change 12.88 % -32.13 % -4.84 % 12.43 % -12.72 %



Quick Ratio first quarter 2026 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 336
Healthcare Sector # 594
Overall Market # 1664


Quick Ratio Statistics
High Average Low
11.84 1.51 0.16
(Sep 30 2014)   (Dec 31 2020)




Financial Statements
Assertio Holdings Inc 's Current Liabilities $ 92 Millions Visit ASRT's Balance sheet
Assertio Holdings Inc 's Cash & cash equivalent $ 72 Millions Visit ASRT's Balance sheet
Source of ASRT's Sales Visit ASRT's Sales by Geography


Cumulative Assertio Holdings Inc 's Quick Ratio

ASRT's Quick Ratio for the trailling 12 Months

ASRT Quick Ratio

 (Mar 31 2026)
12 Months		 (Dec 31 2025)
12 Months		 (Sep 30 2025)
12 Months		 (Jun 30 2025)
12 Months		 (Mar 31 2025)
12 Months
Y / Y Current Liabilities TTM Growth 21.88 % 42.84 % 44.4 % 16.51 % 9.92 %
Y / Y Cash & cash equivalent TTM Growth -10.36 % -4.31 % 14.45 % 17.12 % 20.94 %
Quick Ratio TTM 0.63 0.62 0.7 0.8 0.86
Total Ranking TTM # 4086 # 2338 # 2064 # 2724 # 3144
Seq. Current Liabilities TTM Growth -6.7 % 2.47 % 16.45 % 9.47 % 9.34 %
Seq. Cash & cash equivalent TTM Growth -4.6 % -9.67 % 1.3 % 2.69 % 1.84 %

Quick ratio ranking by company, industry and sector >> Back to ASRT Financial Strength Comparisons >> Go to Compare ASRT Quick Ratio to its Competitors

On the trailing twelve months basis Current Liabilities decreased faster than Assertio Holdings Inc 's average Cash & cash equivalent, this led to increase in in Assertio Holdings Inc 's Quick Ratio to 0.63, Quick Ratio remained below ASRT average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 442 other companies have achieved higher Quick Ratio than Assertio Holdings Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the fourth quarter 2025 from 2338 to 4086.

Explain Quick Ratio?
How much Cash & cash equivalents ASRT´s has?
What are ASRT´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 443
Healthcare Sector # 908
Within the Market # 4086


trailing twelve months Quick Ratio Statistics
High Average Low
3.71 0.79 0.24
(Mar 31 2015)  




Companies with similar Quick Ratio in the quarter ending Mar 31 2026, within Major Pharmaceutical Preparations Industry Quick RatioMar 31 2026 MRQ Cash & cash equivalentMar 31 2026 MRQ Current Liabilities
Pds Biotechnology Corp  2.14 $ 21.660  Millions$ 10.116  Millions
Travere Therapeutics Inc   2.11 $ 264.676  Millions$ 125.437  Millions
Prelude Therapeutics Inc  2.09 $ 81.554  Millions$ 38.959  Millions
Urogen Pharma Ltd   2.09 $ 109.976  Millions$ 52.735  Millions
Mustang Bio inc   2.07 $ 16.258  Millions$ 7.836  Millions
Elicio Therapeutics Inc   2.07 $ 14.948  Millions$ 7.229  Millions
Ptc Therapeutics inc   2.05 $ 1,892.463  Millions$ 923.604  Millions
Galectin Therapeutics Inc   1.93 $ 14.111  Millions$ 7.307  Millions
Avenue Therapeutics Inc   1.90 $ 2.417  Millions$ 1.270  Millions
Vertex Pharmaceuticals Inc  1.87 $ 7,246.700  Millions$ 3,880.600  Millions
Pacira Biosciences inc   1.86 $ 202.180  Millions$ 108.787  Millions
Aspire Biopharma Holdings Inc   1.86 $ 5.857  Millions$ 3.152  Millions
Cryoport inc   1.80 $ 405.680  Millions$ 224.867  Millions
Amphastar Pharmaceuticals Inc   1.79 $ 294.151  Millions$ 164.478  Millions
60 Degrees Pharmaceuticals Inc   1.79 $ 3.338  Millions$ 1.867  Millions
Gossamer Bio Inc   1.76 $ 99.215  Millions$ 56.506  Millions
Actuate Therapeutics Inc   1.72 $ 8.134  Millions$ 4.722  Millions
Decoy Therapeutics Inc   1.72 $ 7.821  Millions$ 4.546  Millions
Therapeuticsmd Inc   1.71 $ 8.419  Millions$ 4.911  Millions
Cellectar Biosciences Inc   1.71 $ 8.347  Millions$ 4.874  Millions
Matinas Biopharma Holdings Inc   1.71 $ 2.398  Millions$ 1.406  Millions
Sarepta Therapeutics Inc   1.70 $ 653.189  Millions$ 383.127  Millions
Lantern Pharma Inc   1.70 $ 6.323  Millions$ 3.718  Millions
Puma Biotechnology Inc   1.70 $ 101.545  Millions$ 59.737  Millions
Petros Pharmaceuticals inc   1.66 $ 4.352  Millions$ 2.623  Millions
Hyperion Defi inc   1.65 $ 7.381  Millions$ 4.473  Millions
Cyclerion Therapeutics Inc   1.65 $ 2.823  Millions$ 1.714  Millions
Zai Lab Limited  1.65 $ 660.092  Millions$ 401.067  Millions
Skye Bioscience Inc   1.64 $ 17.109  Millions$ 10.405  Millions
Rigel Pharmaceuticals Inc  1.64 $ 146.684  Millions$ 89.492  Millions

Date modified: 2026-09-26T07:38:37+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.